MD Anderson Cancer Cente — Houston, Texas

MD Anderson Cancer Cente is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Cente has participated in 1 clinical trials.

Therapeutic areas: Pathway Mutant Myelodysplastic Syndromes, Myelodysplastic Neoplasm, Myeloproliferative Neoplasm.

Sponsors: M.D. Anderson Cancer Center.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Cente?

MD Anderson Cancer Cente has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Cente conducted?

MD Anderson Cancer Cente has 1 clinical trials on record. Their work covers Pathway Mutant Myelodysplastic Syndromes, Myelodysplastic Neoplasm, Myeloproliferative Neoplasm.

Is MD Anderson Cancer Cente accredited by Crixeo Health?

MD Anderson Cancer Cente has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Cente?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.